Novavax (NVAX) Was Upgraded to a Hold Rating at J.P. Morgan
Alpine Immune Sciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Eyenovia (EYEN), Alpine Immune Sciences (ALPN) and GoodRx Holdings (GDRX)
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Dynavax (DVAX) and Natera (NTRA)
Crinetics Pharmaceuticals Analyst Ratings
Oppenheimer Remains a Buy on Revolution Medicines (RVMD)
Natera Analyst Ratings
Analysts' Top Healthcare Picks: Oculis Holding (OCS), Natera (NTRA)
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Wave Life Sciences (WVE) and Intellia Therapeutics (NTLA)
Moderna Analyst Ratings
Key Takeaways From Natera Analyst Ratings
Novavax Analyst Ratings
Natera Analyst Ratings
Oppenheimer Reaffirms Their Buy Rating on Crinetics Pharmaceuticals (CRNX)
Buy Rating on Revolution Medicines With a $44 Target Amid Strong Financials and Upcoming Clinical Catalysts
Revolution Medicines Analyst Ratings
Novavax Analyst Ratings
Natera Analyst Ratings
Novavax Analyst Ratings
B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12